Name: Mochida Pharmaceutical Co Ltd (MCPMF) Dividend History
Creator: GuruFocus
Keywords: MCPMF dividend, Mochida Pharmaceutical Co Ltd dividend history, MCPMF ex-dividend date, MCPMF yield

Mochida Pharmaceutical Co Ltd (MCPMF) pays a dividend yield of 0% ($165.00 per share annually). The payout ratio is 0.35. The 5-year dividend growth rate is -1%. Mochida Pharmaceutical Co Ltd has been paying dividends since 2025.

Below is Mochida Pharmaceutical Co Ltd's complete dividend history, ex-dividend dates, payout ratio trends, and dividend yield charts.

Dividend started since

2025

Years of Dividend History

Years of No Dividend Reduction

Years of Dividend Increase

0% (Trailing)

0% (Forward)

Dividend Yield

0.35

Dividend Payout Ratio

-1%

Growth Rate (5-Year)

Yield on Cost (5-Year)

3-Year Share Buyback Ratio

* Special dividend is not included in the calculation of dividend per share and related fields

Dividend Growth

Mochida Pharmaceutical Co Ltd Dividend History & Ex-Dividend Dates

Complete history of 5 dividend payments by Mochida Pharmaceutical Co Ltd since 2025. Each row shows the ex-dividend date, amount per share, record date, pay date, and declaration date.

Mochida Pharmaceutical Co Ltd (MCPMF) Dividend History
Ex-Dividend Date	Amount	Record Date	Pay Date	Declaration Date
2027-03-30	JPY 42.5	2027-03-31	0000-00-00	2026-05-15
2026-09-29	JPY 42.5	2026-09-30	0000-00-00	2026-05-15
2026-03-30	JPY 40	2026-03-31	2026-06-26	2025-05-12
2025-09-29	JPY 40	2025-09-30	2025-12-01	2025-05-12
2025-03-28	JPY 40	2025-03-31	2025-06-30	2024-05-13

Frequently Asked Questions: MCPMF Dividend

Does Mochida Pharmaceutical Co Ltd (MCPMF) pay a dividend?

Mochida Pharmaceutical Co Ltd (MCPMF) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Mochida Pharmaceutical Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Mochida Pharmaceutical Co Ltd has returned capital to shareholders via buybacks at a rate of 1% over the past 3 years.

What are dividend-paying alternatives to Mochida Pharmaceutical Co Ltd?

For dividend-paying alternatives in Mochida Pharmaceutical Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.

Also check out

High Yield Dividend Stocks in Gurus' Portfolio

Top dividend stocks of Warren Buffett

Top dividend stocks of George Soros

All-in-one Screener

Screen For High Dividend Stocks

Dividend Yield History

Good Dividend Yield % : Close to 3-year high

This is the historical trailing annual dividend yield of Mochida Pharmaceutical Co Ltd. Buying stocks at higher yield relative its historical values is usually more profitable.

Dividend Per Share History

This the dividend history of Mochida Pharmaceutical Co Ltd

Dividend Payout Ratio

This is the historical payout ratio of Mochida Pharmaceutical Co Ltd. If the dividend payout ratio is close to or higher than 1, dividends might not be sustainable.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.